ES507807A0 - Procedimiento para la obtencion de derivados triciclicos de citosina. - Google Patents

Procedimiento para la obtencion de derivados triciclicos de citosina.

Info

Publication number
ES507807A0
ES507807A0 ES507807A ES507807A ES507807A0 ES 507807 A0 ES507807 A0 ES 507807A0 ES 507807 A ES507807 A ES 507807A ES 507807 A ES507807 A ES 507807A ES 507807 A0 ES507807 A0 ES 507807A0
Authority
ES
Spain
Prior art keywords
cytosine
procedure
tricyclic derivatives
formula
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507807A
Other languages
English (en)
Other versions
ES8300111A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES507807A0 publication Critical patent/ES507807A0/es
Publication of ES8300111A1 publication Critical patent/ES8300111A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Fats And Perfumes (AREA)
  • Lubricants (AREA)
ES507807A 1980-12-09 1981-12-09 Procedimiento para la obtencion de derivados triciclicos de citosina. Expired ES8300111A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803046366 DE3046366A1 (de) 1980-12-09 1980-12-09 Tricyclische cytosinderivate zur verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
ES507807A0 true ES507807A0 (es) 1982-10-01
ES8300111A1 ES8300111A1 (es) 1982-10-01

Family

ID=6118700

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507810A Expired ES8400076A1 (es) 1980-12-09 1981-12-09 Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES507807A Expired ES8300111A1 (es) 1980-12-09 1981-12-09 Procedimiento para la obtencion de derivados triciclicos de citosina.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES507810A Expired ES8400076A1 (es) 1980-12-09 1981-12-09 Procedimiento para hidroformilar compuestos olefinicamente insaturados.

Country Status (13)

Country Link
US (1) US4585772A (es)
EP (1) EP0053767B1 (es)
JP (1) JPS57122085A (es)
AT (1) ATE9350T1 (es)
AU (1) AU549240B2 (es)
CA (1) CA1184910A (es)
DE (2) DE3046366A1 (es)
DK (1) DK542781A (es)
ES (2) ES8400076A1 (es)
FI (1) FI813912L (es)
HU (1) HU191038B (es)
IL (1) IL64472A0 (es)
ZA (1) ZA818499B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713383A (en) * 1984-10-01 1987-12-15 Ciba-Geigy Corporation Triazoloquinazoline compounds, and their methods of preparation, pharmaceutical compositions, and uses
US4831013A (en) * 1986-03-20 1989-05-16 Ciba-Geigy Corporation 2-substituted-e-fused-[1,2,4]triazolo[1,5-c]pyrimidines, pharmaceutical compositions, and uses thereof
FR2659329B1 (fr) * 1990-03-09 1994-06-03 Adir Nouveaux derives d'imidazo [1,2-c] quinazoline, leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5158953A (en) * 1991-08-13 1992-10-27 National Science Council 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands
US5539260A (en) * 1994-08-29 1996-07-23 Ford Motor Company Method and apparatus for an automotive security system which permits engine running prior to code comparison
US5637929A (en) * 1996-01-16 1997-06-10 Ford Motor Company Method and apparatus for enhanced vehicle protection
BR0012984A (pt) * 1999-08-04 2002-07-16 Millennium Pharm Inc Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica
US7375125B2 (en) * 1999-08-04 2008-05-20 Ore Pharmaceuticals, Inc. Melanocortin-4 receptor binding compounds and methods of use thereof
GB2453116B (en) * 2007-09-25 2010-03-17 Medical & Pharm Ind Tech & Dev Uses of 2-[piperidinyl]methy1-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one in providing an analgesic effect
EP2852594B1 (en) * 2012-05-21 2016-05-11 Allergan, Inc. Pyrimidino[1,2-c]quinazolinone derivatives as tyrosine kinases inhibitors
CN104583217B (zh) * 2012-06-18 2017-11-17 达特神经科学(开曼)有限公司 取代的噻吩稠合的和呋喃稠合的唑并嘧啶‑5‑(6h)‑酮化合物
JP6420400B2 (ja) * 2017-04-12 2018-11-07 ダート・ニューロサイエンス・（ケイマン）・リミテッド 置換ピリジンアゾロピリミジン−５−（６ｈ）−オン化合物
CN108178759B (zh) * 2018-01-05 2020-06-09 上海瑞纷医药科技有限责任公司 一种α-肾上腺素受体拮抗剂的合成方法
GB2575490A (en) 2018-07-12 2020-01-15 Recordati Ind Chimica E Farmaceutica Spa P2X3 receptor antagonists
EP4389746A3 (en) * 2022-12-21 2024-07-03 Recordati Industria Chimica E Farmaceutica SPA P2x3 receptor antagonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds
US3594379A (en) * 1968-09-16 1971-07-20 Sandoz Ag 2,3-dihydroimidazo(1,2-c)quinazolines
CA986932A (en) * 1970-08-27 1976-04-06 Shigeho Inaba Process for preparing quinazoline derivatives
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE3046366A1 (de) 1982-07-08
FI813912A7 (fi) 1982-06-10
IL64472A0 (en) 1982-03-31
DE3166084D1 (en) 1984-10-18
DK542781A (da) 1982-06-10
JPS57122085A (en) 1982-07-29
ATE9350T1 (de) 1984-09-15
FI813912L (fi) 1982-06-10
CA1184910A (en) 1985-04-02
AU549240B2 (en) 1986-01-23
US4585772A (en) 1986-04-29
HU191038B (en) 1986-12-28
EP0053767B1 (de) 1984-09-12
ES507810A0 (es) 1983-10-16
AU7831781A (en) 1982-06-17
EP0053767A1 (de) 1982-06-16
ES8400076A1 (es) 1983-10-16
ZA818499B (en) 1982-11-24
ES8300111A1 (es) 1982-10-01

Similar Documents

Publication Publication Date Title
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
ES507807A0 (es) Procedimiento para la obtencion de derivados triciclicos de citosina.
PT77898A (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
IL58775A (en) Hydroxyethyl-azole compounds,their production and pharmaceutical compositions containing them
NZ192195A (en) 1-triazolyl-2-hydroxy-2-phenyl-3-aryl-propanes and pharmaceutical compositions
ES499782A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
ES519690A0 (es) Procedimiento para la obtencion de azolil-fenoxi-tetrahidrofuran-2-iliden-metanos.
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
ES495826A0 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
ES492537A0 (es) Procedimiento para la obtencion de pseudo-trisacaridos
ES488301A0 (es) Procedimiento para la obtencion de dehidropeptidos
JPS5566578A (en) Novel 22substitutedd33heterocyclic indoles* their manufacture and medical composition containing them
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
EP0036991B1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions